Application of 18F-Fluorodeoxyglucose and PET in Evaluation of the Diabetic Foot.

[1]  G. Mariani,et al.  Inflammation and infection: imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  H. Aro,et al.  Comparison of 18F-FDG and 68Ga PET imaging in the assessment of experimental osteomyelitis due to Staphylococcus aureus , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  John L. Johnson,et al.  Osteomyelitis in diabetic foot ulcers , 2005, Postgraduate medicine.

[4]  Ora Israel,et al.  The diabetic foot: initial experience with 18F-FDG PET/CT. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  J. Knuuti,et al.  Efficacy of bioabsorbable antibiotic containing bone screw in the prevention of biomaterial-related infection due to Staphylococcus aureus. , 2005, Bone.

[6]  A. Alavi,et al.  Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders. , 2005, Radiologic clinics of North America.

[7]  W. Wadsak,et al.  In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  R. Tiling,et al.  Preoperative Imaging of Charcot Neuroarthropathy in Diabetic Patients: Comparison of Ring PET, Hybrid PET, and Magnetic Resonance Imaging , 2004, Foot & ankle international.

[9]  Benjamin A Lipsky,et al.  Is this bone infected or not? Differentiating neuro-osteoarthropathy from osteomyelitis in the diabetic foot , 2004, Current diabetes reports.

[10]  W. Wadsak,et al.  [18F]Ciprofloxacin, a New Positron Emission Tomography Tracer for Noninvasive Assessment of the Tissue Distribution and Pharmacokinetics of Ciprofloxacin in Humans , 2004, Antimicrobial Agents and Chemotherapy.

[11]  J. Knuuti,et al.  Comparative 18F-FDG PET of experimental Staphylococcus aureus osteomyelitis and normal bone healing. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  C. Sahlmann,et al.  Dual time point 2-[18F]fluoro-2′-deoxyglucose positron emission tomography in chronic bacterial osteomyelitis , 2004, Nuclear medicine communications.

[13]  K. Harding,et al.  Diagnosing foot infection in diabetes. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  S Osman,et al.  In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography , 2004, British Journal of Cancer.

[15]  Benjamin A Lipsky.  A report from the international consensus on diagnosing and treating the infected diabetic foot , 2004, Diabetes/metabolism research and reviews.

[16]  Thomas F Hany,et al.  FDG PET for differentiation of infection and aseptic loosening in total hip replacements: comparison with conventional radiography and three-phase bone scintigraphy. , 2004, Radiology.

[17]  H. Nelson,et al.  Bone scanning in the diagnosis of acute osteomyelitis , 1980, European Journal of Nuclear Medicine.

[18]  A. King,et al.  Imaging of bone infection with labelled white blood cells role of contemporaneous bone marrow imaging , 2004, European Journal of Nuclear Medicine.

[19]  E. Sella,et al.  Imaging modalities of the diabetic foot. , 2003, Clinics in podiatric medicine and surgery.

[20]  P. Scuffham,et al.  The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S. , 2003 .

[21]  A. Alavi,et al.  Applications of fluorodeoxyglucose positron emission tomography in the diagnosis of infection , 2003, Nuclear medicine communications.

[22]  A. Alavi,et al.  Rapid normalization of osseous FDG uptake following traumatic or surgical fractures , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[23]  J. Karp,et al.  Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5 , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[24]  G. V. von Schulthess,et al.  FDG positron emission tomography for differentiation of degenerative and infectious endplate abnormalities in the lumbar spine detected on MR imaging. , 2002, AJR. American journal of roentgenology.

[25]  W. Morrison,et al.  Work-up of the diabetic foot. , 2002, Radiologic clinics of North America.

[26]  M. Schweitzer,et al.  MR image analysis of pedal osteomyelitis: distribution, patterns of spread, and frequency of associated ulceration and septic arthritis. , 2002, Radiology.

[27]  Abass Alavi,et al.  18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. , 2002, Seminars in nuclear medicine.

[28]  T. H. Lee,et al.  Charcot foot: the diagnostic dilemma. , 2001, American family physician.

[29]  H. Zhuang,et al.  Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders? , 2001, Nuclear medicine communications.

[30]  H. Minn,et al.  Pharmacokinetics of [18F]FETNIM: A Potential Hypoxia Marker for PET , 2001 .

[31]  C. Koch,et al.  Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazoles , 2001, Cancer Chemotherapy and Pharmacology.

[32]  A. Alavi,et al.  F-18 FDG positron emission tomography to differentiate diabetic osteoarthropathy from septic arthritis. , 2001, Clinical nuclear medicine.

[33]  S. Hahn,et al.  Hypoxia in human intraperitoneal and extremity sarcomas. , 2001, International journal of radiation oncology, biology, physics.

[34]  I. Heyligers,et al.  Detection of osteomyelitis using FDG and positron emission tomography. , 2001, The Journal of arthroplasty.

[35]  C. Koch,et al.  [18F]-EF5, a marker for PET detection of hypoxia: synthesis of precursor and a new fluorination procedure. , 2001, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[36]  A. Alavi,et al.  The promising role of 18F-FDG PET in detecting infected lower limb prosthesis implants. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  M. Schweitzer,et al.  MR imaging of the diabetic foot. , 2001, Magnetic resonance imaging clinics of North America.

[38]  A. Boulton,et al.  The diabetic foot: the scope of the problem. , 2000, The Journal of family practice.

[39]  G. V. von Schulthess,et al.  Infection imaging using whole-body FDG-PET , 2000, European Journal of Nuclear Medicine.

[40]  H. Biersack,et al.  Fluorine-18 fluorodeoxyglucose positron emission tomography in infectious bone diseases: results of histologically confirmed cases , 2000, European Journal of Nuclear Medicine.

[41]  A. Alavi,et al.  Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. , 2000, Clinical Nuclear Medicine.

[42]  S M Evans,et al.  Detection of hypoxia in human squamous cell carcinoma by EF5 binding. , 2000, Cancer research.

[43]  A. Alavi,et al.  Noninvasive detection of tumor hypoxia using the 2-nitroimidazole [18F]EF1. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[44]  Benjamin A Lipsky.  A current approach to diabetic foot infections , 1999, Current infectious disease reports.

[45]  A. Rahmouni,et al.  The value of combined radionuclide and magnetic resonance imaging in the diagnosis and conservative management of minimal or localized osteomyelitis of the foot in diabetic patients. , 1999, Metabolism: clinical and experimental.

[46]  W. G. Batte,et al.  Osteomyelitis of the foot: relative importance of primary and secondary MR imaging signs. , 1998, Radiology.

[47]  S. Erickson,et al.  Detection of osteomyelitis in the neuropathic foot: nuclear medicine, MRI and conventional radiography. , 1998, Clinical nuclear medicine.

[48]  M. Tomas,et al.  Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[49]  J. Apelqvist,et al.  Clinical Characteristics and Outcome in 223 Diabetic Patients with Deep Foot Infections , 1997, Foot & ankle international.

[50]  W. Eyler,et al.  Osteomyelitis of the diabetic foot: MR imaging-pathologic correlation. , 1997, Radiology.

[51]  P. Blume,et al.  Diagnosis of pedal osteomyelitis with Tc-99m HMPAO labeled leukocytes. , 1997, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons.

[52]  V. Ladam-Marcus,et al.  MR imaging of osteomyelitis and neuropathic osteoarthropathy in the feet of diabetics. , 1996, Radiographics : a review publication of the Radiological Society of North America, Inc.

[53]  D. Armstrong,et al.  Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus. , 1996, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons.

[54]  Y Akashi,et al.  FDG-PET in infectious lesions: The detection and assessment of lesion activity , 1996, Annals of nuclear medicine.

[55]  M. Sasaki,et al.  A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma , 1996, Annals of nuclear medicine.

[56]  J. Johnson,et al.  Prospective Study of Bone, lndium-111-Labeled White Blood Cell, and Gallium-67 Scanning for the Evaluation of Osteomyelitis in the Diabetic Foot , 1996, Foot & ankle international.

[57]  D. Nardone.  Probing to bone in infected pedal ulcers. , 1995, JAMA.

[58]  P. Hecht,et al.  Osteomyelitis in feet of diabetics: clinical accuracy, surgical utility, and cost-effectiveness of MR imaging. , 1995, Radiology.

[59]  J. Esterhai,et al.  Magnetic Resonance Imaging for the Diagnosis of Osteomyelitis in the Diabetic Patient with a Foot Ulcer , 1994, Foot & ankle international.

[60]  A. Stagnaro-Green,et al.  Leukocyte Scanning With 111In Is Superior to Magnetic Resonance Imaging in Diagnosis of Clinically Unsuspected Osteomyelitis in Diabetic Foot Ulcers , 1992, Diabetes Care.

[61]  L. Rosenthall.  Radionuclide investigation of osteomyelitis. , 1992, Current opinion in radiology.

[62]  M. Brown,et al.  Diagnosis of osteomyelitis of the foot in diabetic patients: value of 111In-leukocyte scintigraphy. , 1991, AJR. American journal of roentgenology.

[63]  P. Weatherall,et al.  Osteomyelitis: characteristics and pitfalls of diagnosis with MR imaging. , 1991, Radiology.

[64]  J. L. Marsh,et al.  Indium-111-leukocyte/technetium-99m-MDP bone and magnetic resonance imaging: difficulty of diagnosing osteomyelitis in patients with neuropathic osteoarthropathy. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[65]  A. Alavi,et al.  Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques. , 1989, Archives of internal medicine.

[66]  W. Yuh,et al.  Osteomyelitis of the foot in diabetic patients: evaluation with plain film, 99mTc-MDP bone scintigraphy, and MR imaging. , 1989, AJR. American journal of roentgenology.

[67]  O. Israel,et al.  Osteomyelitis and soft-tissue infection: differential diagnosis with 24 hour/4 hour ratio of Tc-99m MDP uptake. , 1987, Radiology.

[68]  F. Datz,et al.  Value of a 24-hour image (four-phase bone scan) in assessing osteomyelitis in patients with peripheral vascular disease. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[69]  V. D. Gaines,et al.  The radiology of osteomyelitis. , 1983, The Orthopedic clinics of North America.